High-dose methotrexate for patients with osteosarcoma in resource-poor settings
BACKGROUND: Methotrexate (MTX) is one of the most widely used antifolate analogs. It is active against both hematological and solid tumors. Healthcare providers are reluctant to use high-dose MTX (HDMTX) on patients in various institutions, especially in resource-poor settings. Not much data are ava...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wolters Kluwer Medknow Publications
2026-07-01
|
| Col·lecció: | Annals of Oncology Research and Therapy |
| Matèries: | |
| Accés en línia: | https://journals.lww.com/10.4103/aort.aort_39_25 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|